Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why should they say that when it’s only a strategy.
IT's called a smash and grab.
Under 10 cents so what. Please don’t anybody be fooled by this.
What was the reason please.
The potential future value of Brilacidin hasn’t gone away and Ipix’s strategic investment in unique laser technology is intriguing too.
They’re not provable and most people wouldn’t print such base accusations.
Interesting stuff frenchbroad and, if true, is a perfect example of price disconnect.
I think a lot of us have moved on from the COVID-19 trial. As you know, the anti viral properties of Brilacidin are still being being tested against multiple diseases and we await the outcome of these tests. Also, as you know, the future of Brilacidin has not been decided yet.
The bio labs like something about Brilacidin or they wouldn’t be still testing. I’ll be a sport and go with them at 4cents.
Just as I said all about the non submission of results.
What was the purpose of another post about the non submission of data?
Was the buy volume higher than the sell volume? Of course it was.Nothing to do with how Ihub extrapolated the buy sells. Ridiculous argument.
Further, the market maker book positions play a role as does availability of supply above the current price.
If buying volume had not been higher than the selling volume then why would the price increase by 14%.
The obvious is what the government could do for Ipix both scientifically and fiscally. The obvious is Ipix has a chance to be successful with Brilacidin because of that help. The obvious is Ipix is beaten down but far from out.
What it shows is if Ipix wraps a deal, as is possible at any time, the first flip will likely be to 40 cents.
It is clearly a good thing to have done in trying to move Brilacidin treatments forwards.
You spend a lot of time accusing Ipix authors interjecting their hope against facts when, of course, they would lose far more by doing so. Do you really believe scientists would bother with Brilacidin if Ipix authors influenced their reported findings? Of course not, just a conspiracy theory.
I would choose the scientists comprehension of their own data every time.
Government or otherwise I am looking for a sponsor to take Brilacidin forwards and therefore cut the need for heavy dilution.
My reply was to Zandant's four word comment "Doesn't work in humans" (brilacidin). I suggested he contact Alfasigma to see if they agree with him. It seems to work on one's skin and at some point we may get the word it works internally also.
Ask Alfasigma. Two word reply!
I don’t come on here everyday to mock people I come on here as a shareholder expecting to profit from my investment. The prospect for making a profit is likely in my favor as the share price languishes here at $0.0477 per share. This board is a bit of fun to to crow about my investment and it’s potential future, that’s all. I am not a professional working this board to make my living.
I believe the software console will be completely unique to Squalus and will drive the laser to run circles round their competition. Literally.
Let’s see where the NIH takes us shall we.
Did you change your reply?
Do you know anything about ablation technology and future trends of the same?
Phase 1, 2 then 3. Is that it LR, don’t know what you are getting at.
Brilacidin is much more than just COVID and Squalus could be bigger than Brilacidin, maybe many times over. People are buying into a very low market cap as they can envision that the Squalus deal changes Ipix from very slow progress to potentially a very exciting laser technology investment.
Be careful the combine of Ipix and Squalus might just catch on. Fiber optic controlled laser surgery sounds pretty good to me.
The Squalus investment puts a really nice twist in the tale of Ipix. When news breaks on their laser technology Ipix will be the only way to invest in them. Combine that with more interest in Brilacidin our share price could make quite a move.
I don’t think you can count on news flow remaining the same as who knows what we will get from Squalus.
Ipix is a two pronged company with potential break through technology and sells for 3 cents. The latest addition of laser surgery using fiber optics that can contort to a tumors shape and size is really interesting. Wait for news on this and wait for Brilacidin news from Alfasigma upcoming in the near future.
I believe his purchase of Brilacidin was a good one but poorly managed thereafter. His purchase of shares in Squalus could also be smart and this time they manage it. Time will tell.
There always has to be some type of conspiracy theory. Nothing at face value anymore.
It almost seems as if everybody is too scared to be positive about Squalus and their very exciting technology. I expect quite a news flow from them.
As time goes by and we are forced to twiddle our thumbs waiting for news from Alfasigma and for news of any sort concerning Brilacidin or our new venture it will be interesting to see if a future for Ipix from the ashes of our current state can be reborn. A glimpse forward is all we need to bring in new chance takers at such a low share price.
That’s got to be 2cents worth right now!
There have been plenty of times I wished I had shares in private companies with exciting new technology. If Squalus’s new fiber optics laser technology takes off while still private then Ipix shares will be the only way to buy into it.
Anything that can breath life back into Ipix and can show a way forward I’ll take. Moving the needle is paramount so let’s see what happens.